2016-11-15T10:55:44-06:00 2015-12-31 841158905 CAUSEY DEMGEN & MOORE PC 1125 17TH ST STE 1450 DENVER CO 80202 990 2015-01-01 200499338 INTERNATIONAL ASSOCIATION FOR THE STUDY OF LUNG CANCER INTE 7203252955 13100 E COLFAX AVE NO 10 AURORA CO 80011 DAVID GANDARA MD TREASURER 7203252955 2016-08-08 1 MICHAEL GRAEF P00038238 3032962229 2015 2017-02-10 21:41:12Z DAVID GANDARA MD 13100 E COLFAX AVE SUITE 10 AURORA CO 80011 16706117 0 X WWW.IASLC.ORG X 2003 CO TO PROMOTE THE STUDY OF THE ETIOLOGY, EPIDEMIOLOGY, PREVENTION, DIAGNOSIS, TREATMENT AND ALL OTHER ASPECTS OF LUNG CANCER AND OTHER THORACIC MALIGNANCIES.TO PROVIDE EDUCATION AND INFORMATION ABOUT LUNG CANCER AND OTHER THORACIC MALIGNANCIES TO IASLC MEMBERS, TO THE MEDICAL COMMUNITY AT LARGE, AND TO THE PUBLIC.TO USE ALL AVAILABLE MEANS TO ELIMINATE LUNG CANCER AND OTHER THORACIC MALIGNANCIES AS A HEALTH THREAT FOR THE INDIVIDUAL PATIENT AND THROUGHOUT THE WORLD. 20 20 11 0 0 0 1064804 784564 4105371 13937168 403816 268591 21252 21252 5595243 15011575 450000 340000 0 0 999912 973298 0 0 0 3500416 10139879 4950328 11453177 644915 3558398 12541674 16765173 4125893 5158928 8415781 11606245 X TO PROMOTE THE STUDY OF THE ETIOLOGY, EPIDEMIOLOGY, PREVENTION, DIAGNOSIS, TREATMENT AND ALL OTHER ASPECTS OF LUNG CANCER AND OTHER THORACIC MALIGNANCIES.TO PROVIDE EDUCATION AND INFORMATION ABOUT LUNG CANCER AND OTHER THORACIC MALIGNANCIES TO IASLC MEMBERS, TO THE MEDICAL COMMUNITY AT LARGE, AND TO THE PUBLIC.TO USE ALL AVAILABLE MEANS TO ELIMINATE LUNG CANCER AND OTHER THORACIC MALIGNANCIES AS A HEALTH THREAT FOR THE INDIVIDUAL PATIENT AND THROUGHOUT THE WORLD. 0 0 340000 340000 260000 FELLOWSHIPS - PROVIDED TO TRAIN NEXT GENERATION OF LUNG CANCER LEADERS. FUNDING FOR IASLC FELLOWSHIP AND YOUNG INVESTIGATOR AWARDS PROVIDES FOR TRAINING OF FELLOWS AND YOUNG INVESTIGATORS WHO WISH TO PURSUE A CAREER IN DIAGNOSIS, TREATMENT, LABORATORY RESEARCH OR OTHER ASPECTS OF LUNG TUMORS.IASLC FELLOWSHIPS AND YOUNG INVESTIGATOR AWARDS ARE GRANTED FOR TWO YEARS. THE STIPEND FOR AN IASLC GRANT IS $40,000 PER YEAR. FUNDING FOR THE SECOND YEAR IS CONTINGENT UPON A SATISFACTORY PROGRESS REPORT AT THE ONE YEAR MARK. 974969 619938 PUBLICATIONS-PROVIDE EDUCATION TO THE WORLD WIDE LUNG CANCER COMMUNITY REGARDING THE LATEST ADVANCES IN LUNG CANCER TREATMENT. 9279897 9070787 MEETING AND WEB SEMINARS TO DISSEMINATE INFORMATION REGARDING THE LATEST ADVANCES IN LUNG CANCER TREATMENT. VARIOUS OTHER ACTIVITIES 10594866 1 1 0 0 0 0 0 0 0 0 1 1 0 0 0 1 1 0 0 0 1 1 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 44 0 1 11 1 0 0 0 0 0 0 0 0 X 20 20 1 0 0 0 0 0 0 1 1 0 0 0 1 1 1 0 0 1 1 0 CO X FRED HIRSCH MD PHD 7203252951 13100 E COLFAX AVE SUITE 10 AURORA CO 80111 TONY MOK MD IMMEDIATE PAST PRESIDENT 5.00 X X 0 0 0 FRED HIRSCH MD PHD CEO/CONGRESS PRESIDENT 30.00 X X 0 271914 47606 GIORGIO SCAGLIOTTI MD PHD PRESIDENT ELECT 3.00 X 0 0 0 DAVID CARBONE MD PHD PRESIDENT 10.00 X 0 0 0 MICHAEL BOYER MD DIRECTOR 3.00 X 0 0 0 DAVID HARPOLE MD DIRECTOR 3.00 X 0 0 0 NORIHIKO IKEDA MD PHD DIRECTOR 3.00 X 0 0 0 ROBERT PIRKER MD DIRECTOR 3.00 X 0 0 0 MIYAKO SATOUCHI MD PHD DIRECTOR 3.00 X 0 0 0 HEATHER WAKELEE MD DIRECTOR 3.00 X 0 0 0 DAVID GANDARA MD TREASURER 10.00 X 0 0 0 PASI JANNE MD PHD DIRECTOR 3.00 X 0 0 0 WILLIAM TRAVIS MD DIRECTOR 3.00 X 0 0 0 LAURIE GASPAR MD MBA DIRECTOR 3.00 X 0 0 0 SOLANGE PETERS MD PHD PDMER DIRECTOR 3.00 X 0 0 0 KEITH KERR BSCMDCHBFRCPATHFRCPE DIRECTOR 3.00 X 0 0 0 FRANCOISE MORNEX MD PHD DIRECTOR 3.00 X 0 0 0 YI-LONG WU MD DIRECTOR 3.00 X 0 0 0 YUCHIRO OHEMD DIRECTOR 3.00 X 0 0 0 MARTIN RECK MD PHD DIRECTOR 3.00 X 0 0 0 PIA HIRSCH DIRECTOR OF EDUCATION 40.00 X 112984 0 15808 112984 271914 63414 1 0 1 0 UNIVERSITY PHYSICIANS INC PO BOX 110247 AURORA CO 800420247 REIMBURSEMENT OF EXPENSES 565655 FAIRMONT HOTEL 101 WILSHIRE BOULEVARD SANTA MONICA CA 90401 MEETING EXPENSES 387232 WOLTERS KLUWER HEALTH INC 16705 COLLECTION CENTER DRIVE CHICAGO IL 60693 PUBLISHER 374742 SMG - COLORADO CONVENTION CENTER 700 14TH STREET DENVER CO 80202 MEETING EXPENSES 278393 INTERNATIONAL CONFERENCE SERVICES 1201 W PENDER ST STE 300 VANCOUVER BC CA V6E 2V2 CONFERENCES 270728 5 704047 80517 784564 MEETING INCOME 541900 11994088 8931645 3062443 PUBLICATIONS 541900 1460938 619938 841000 FELLOWSHIPS 541900 260000 260000 WEB SEMINARS 541900 222142 139142 83000 13937168 130557 130557 21252 0 21252 21252 21252 1832576 1694542 138034 138034 138034 15011575 9950725 0 4276286 160000 160000 20000 20000 160000 160000 384898 288674 96224 406956 305217 101739 181444 136083 45361 10564 10564 58260 58260 70829 70829 15334 15334 54234 40676 13558 37027 27770 9257 111108 83331 27777 22796 22796 8068944 7953445 115499 58067 43550 14517 18499 18499 PUBLICATIONS 877593 877593 COMMITTEES 272488 272488 WEB SEMINARS 127133 127133 FOREIGN CURRENCY GAIN/L 83372 83372 253631 76110 177521 11453177 10594866 858311 0 3819760 8263420 1955176 2463012 204374 1452489 374201 198875 24400 396864 471352 410485 258366 219670 152119 4498840 4812295 12541674 16765173 559881 357390 3566012 4453614 347924 4125893 5158928 X 8415781 11606245 8415781 11606245 12541674 16765173 X 3558398 -367933 -1 X X 0 1 X 1 0 X 6740411 578966 795240 1064804 784563 9963984 6240172 3249357 10204479 4105370 13879388 37678766 12980583 3828323 10999719 5170174 14663951 47642750 0 0 0 47642750 114351 119716 119471 148179 151809 653526 114351 119716 119471 148179 151809 653526 13094934 3948039 11119190 5318353 14815760 48296276 0.98650 0.98310 0.01350 0.01690 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 95338 37446 57892 198397 138538 59859 116750 82382 34368 152119 ALTERNATIVE INVESTMENTS 603414 F OTHER SECURITIES 4208881 F 4812295 X 14560270 -367933 -367933 14928203 83372 83372 15011575 11369806 0 11369806 83371 83371 11453177 PART X, LINE 2: THE ASSOCIATION HAS ADOPTED GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES. AFTER EVALUATING THE TAX POSITIONS TAKEN, NONE ARE CONSIDERED TO BE UNCERTAIN; THEREFORE, NO AMOUNTS HAVE BEEN RECOGNIZED AS OF DECEMBER 31, 2015 AND 2014. THE ASSOCICATION IS NO LONGER SUBJECT TO U.S. FEDERAL INCOME TAX EXAMINATIONS FOR YEARS PRIOR TO 2010. PART XI, LINE 4B - OTHER ADJUSTMENTS: FOREIGN CURRENCY LOSS 83,372. PART XII, LINE 4B - OTHER ADJUSTMENTS: FOREIGN CURRENCY LOSS 83,372. ROUNDING ADJUSTMENT -1. 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES SCIENTIFIC CONFERENCE 18697 0 0 0 0 0 0 18697 0 18697 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. 100000 WIRE CASH EAST ASIA AND THE PACIFIC - AUSTRALIA, BRUNEI, BURMA, CAMBODIA, SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. 60000 WIRE CASH 0 0 0 0 0 0 PART I, LINE 2: 1. GRANTS WILL BE INITIALLY REVIEWED BY THE COMMITTEE CHAIR FOR COMPLETENESS. INCOMPLETE SUBMISSIONS OR GRANTS SUBMITTED AFTER THE DEADLINE WILL BE RETURNED TO THE PI IN 48 HOURS. 2. EACH MEMBER OF THE SCIENTIFIC REVIEW COMMITTEE WILL RIGOROUSLY REVIEW THE APPLICATIONS. APPLICATIONS WILL BE SCORED ON FOUR CRITERIA: A. POTENTIAL OF THE CANDIDATE: IS THE CANDIDATE COMMITTED TO A CAREER IN LUNG CANCER RESEARCH? DOES THE CANDIDATE HAVE BASIC TRAINING RELATED TO THE PROJECT PROPOSED? PUBLISHED/SUBMITTED PAPERS OR ABSTRACTS CURRENT OR PENDING GRANT SUBMISSIONS STRONG LETTERS OF SUPPORT B. SCIENTIFIC MERIT OF THE PROJECT: IS THE PROPOSAL ORIGINAL? IS THE PROPOSAL CLEAR & CONCISE? ARE THE SPECIFIC AIMS REASONABLE? IS THE METHODOLOGY REASONABLE TO ACCOMPLISH THE OBJECTIVES? CAN THE PROJECT BY COMPLETED IN THE 2 YEAR TIME FRAME? C. SIGNIFICANCE OF PROJECT: IS THE PROJECT WITHIN THE IASLC SCOPE? WHAT WILL THIS INFORMATION CONTRIBUTE TO KNOWLEDGE IN THIS FIELD? DO THESE RESULTS SIGNIFICANTLY IMPROVE THE APPLICATION OF KNOWLEDGE OF LUNG CANCER? WILL THESE DATA STIMULATE FURTHER SCIENTIFIC RESEARCH INTO LUNG CANCER? D. STRENGTH OF THE PI/INSTITUTIONAL SUPPORT (FOR FELLOWSHIP GRANTS): IS THE PI DEDICATED TO ASSISTING IN THE EXECUTION AND COMPLETION OF THE PROJECT? IS THE PI OF GOOD STANDING IN THE FIELD OF LUNG CANCER RESEARCH? DOES THE PI HAVE SUFFICIENT GRANT SUPPORT FOR THE FELLOW TO COMPLETE THE PROJECT IF REQUIRED? DOES THE INSTITUTION HAVE THE NECESSARY RESOURCES TO SUPPORT THE PROJECT? SCORES WILL RANGE FROM 1-5. 5 - OUTSTANDING 4 - EXCELLENT 3 - GOOD 2 - POOR 1 - UNACCEPTABLE TOTAL SCORES WILL THEN BE TABULATED, AVERAGED, AND THE CANDIDATE RANKED. THE COMMITTEE WILL MEET BY CONFERENCE CALL TO SELECT THE AWARDEES. 3. PROGRESS REPORTS FROM YEAR 1 WILL BE REVIEWED BY THE COMMITTEE CHAIR. PART I, LINE 3: BUDGET REVIEW AND APPROVAL WAS REQUIRED FOR EACH CONFERENCE. 1 BOSTON CHILDREN'S HOSPITAL PO BOX 414413 BOSTON MA 022414413 042103881 20000 SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. DANA-FARBER CANCER INSTITUTE INC 450 BROOKLINE AVENUE BP418 BOSTON MA 02215 042263040 80000 SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. UNIVERSITY OF COLORADO DENVER - ANSCHUTZ MEDICAL CAMPUS 13001 E 17TH PL AURORA CO 80045 846000555 40000 SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. YALE UNIVERSITY SCHOOL OF MEDICINE 47 COLLEGE ST SUITE 203 NEW HAVEN CT 065208047 060646973 20000 SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. SUPPORT DEVELOPMENT OF RESEARCH & YOUNG MEDICAL PROFS. IN THORACIC ONCOLOGY. 1 20000 1 X X X 0 0 0 0 0 0 0 0 0 FRED HIRSCH MD PHD CEO/CONGRESS PRESIDENT 0 271914 0 0 0 0 0 0 0 47606 0 319520 0 0 FORM 990, PART VI, SECTION A, LINE 2 PIA HIRSCH, DIRECTOR OF EDUCATION AND FRED HIRSCH, CEO/CONGRESS PRESIDENT, MD, PHD, ARE SPOUSES. FORM 990, PART VI, SECTION B, LINE 11 THE TREASURER AND THE FINANCE COMMITTE REVIEW THE RETURN PRIOR TO THE FILING OF FORM 990. THE TAX RETURN IS AVAILABLE TO THE BOARD FOR REVIEW FOLLOWING THE FILING OF FORM 990. FORM 990, PART VI, SECTION B, LINE 12C THROUGH YEARLY REVIEWS FORM 990, PART VI, SECTION B, LINE 15 THROUGH YEARLY REVIEWS FORM 990, PART VI, SECTION C, LINE 19 AVAILABLE UPON REQUEST FORM 990, PART XI, LINE 9: ROUNDING -1. FORM 990, PART XII, LINE 2C NO CHANGES TO THE PROCESS.